The BRCA1/2 mutation is associated with an increased risk of breast and/or ovarian cancer, with carriers of the mutation having a risk respectively of 72% and 44% for BRCA1 and 69% and 17% for BRCA2.1 The gene discussed is BRCA1; the disease is ovarian carcinoma.